This inventor holds 1 USPTO granted patent. Top assignee: Nanohybrid Co., Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Youn-Soo Sohn: Innovator in Anticancer Agents
Introduction
Youn-Soo Sohn is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel therapeutic agents. His work focuses on creating targeted and effective solutions for combating cancer.
Latest Patents
Youn-Soo Sohn holds a patent for a "Tumor selective and biodegradable cyclotriphosphazene-platinum(II) conjugate anticancer agent, and preparation method thereof." This patent discloses a novel cyclotriphosphazene-platinum(II) complex conjugate anticancer agent that demonstrates high selectivity to tumor tissues. The agent utilizes the enhanced permeability and retention effect in tumor tissues, making it a promising candidate for cancer therapy. He has 1 patent to his name.
Career Highlights
Youn-Soo Sohn is associated with Nanohybrid Co., Ltd., where he continues to advance his research in the field of anticancer agents. His work has garnered attention for its potential to improve treatment outcomes for cancer patients.
Collaborations
He collaborates with notable colleagues, including Ji-Young Yu and Yong-Joo Jun, who contribute to his research efforts and innovations in the field.
Conclusion
Youn-Soo Sohn is a dedicated inventor whose work in developing targeted anticancer agents showcases his commitment to improving cancer treatment. His innovative approach and collaboration with fellow researchers highlight the importance of teamwork in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile